Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure

Details for Australian Patent Application No. 2009292216 (hide)

Owner Acorda Therapeutics, Inc.

Inventors Caggiano, Anthony; Ganguly, Anindita; Iaci, Jennifer; Parry, Tom

Agent Pizzeys

Pub. Number AU-A-2009292216

PCT Pub. Number WO2010/030317

Priority 61/135,171 17.07.08 US

Filing date 17 July 2009

Wipo publication date 18 March 2010

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

24 February 2011 PCT application entered the National Phase

  PCT publication WO2010/030317 Priority application(s): WO2010/030317

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009292217-Incubation system with low temperature enclosure

2009292209-Microbial based chlorinated ethene destruction